Hints and tips:
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
...In a research note on Monday, Cowen argued that a number of the large pharmaceutical groups, led by Eli Lilly, Sanofi-Aventis and Pfizer, would be worth more if they divested separable business units, which...
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
...Diabetes medications still make up about 17 per cent of Lilly’s $22bn revenues, but in recent years it has lost ground to rivals such as Merck and Sanofi-Aventis....
...Sanofi-Aventis of France, which originally developed clopidogrel, known by the brand name Plavix, stressed that its versions and those of its partner Bristol Myers-Squibb, were not affected by the recall...
...Insiders say Chris Viehbacher, the German-Canadian appointed in late 2008 as chief executive of Sanofi-Aventis of France, fought late last year to combine his role with that of chairman once Jean-Francois...
...of some of sanofi-aventis’ Prescription Medicines to Over-the-Counter Products – Chattem Management to Lead the U.S....
...But this is no longer the case in Europe where the likes of GSK, Sanofi-Aventis and Astra Zeneca all have separate chairmen and chief executives....
...But this is no longer the case in Europe where the likes of Sanofi-Aventis, GlaxoSmithKline and AstraZeneca all have separate chairmen and chief executives....
...In pharmaceuticals, the government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow it up....
...The bodies collaborating on the RV144 trial in Thailand – including the US Army and National Institutes of Health, the Thai health ministry and Sanofi Aventis, the giant French drug company – could hardly...
...A study by a British medical journal reported that a blood-thinning pill developed by the company worked better than Plavix, a rival drug made by Sanofi-Aventis....
...Innovative pharmaceutical companies such as GlaxoSmithKline in the UK, Sanofi-Aventis in France and Pfizer in the US are expanding their generic drugs activities, but concentrating on faster growing emerging...
...Chris Viehbacher, who took over Sanofi-Aventis late last year, says: “Big acquisitions? You would never say never....
...Then again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter offers....
...Swiss drugmaker Novartis gained 23.7 per cent to SFr59.50 while in France, Sanofi-Aventis climbed 17.2 per cent to €44.44. Germany’s BMW was boosted by an upgrade from Goldman Sachs....
...Mr Buffett also added to his positions in Ingersoll-Rand, a maker of refrigeration gear, and Sanofi Aventis, the French drugmaker....
...Sanofi-Aventis is currently bidding against a rival consortium to buy control of Zentiva, a Czech generic drugs manufacturer, as it expands its franchise into eastern and central Europe, where generics are...
...Even Jean-François Dehecq, 67, the powerful head of Sanofi-Aventis of France – a group he created through mergers over 30 years – stepped aside as chief executive at the start of this year in favour of his...
...Shares in Bristol-Myers Squibb fell 3.3 per cent to $27.59 after reports of a break-down in the merger talks with Sanofi-Aventis ....
...Shares in Sanofi-Aventis gained 2.5 per cent to €70.30....
...Sanofi-Aventis faces its own court battle over generic competition for its blood-thinning drug Plavix....
International Edition